Denmark’s economy is expected to grow by as much as 4.5 percent this year, mainly driven by strong pharmaceutical exports. This is according to the European Commission’s autumn forecast.
GDP growth is then expected to slow to 2.0 percent in 2027 and 2.1 percent in 2028, as domestic demand takes over as the main growth engine.
The Danish economy grew strongly in the first half of the year, above all thanks to exports from the pharmaceutical industry, while other parts of the economy developed at a more moderate pace.
The Commission points out that developments in the US market have played an important role, including through an agreement on lower prices for certain obesity and diabetes medicines in exchange for expanded market access, as well as the launch of a new tablet-based weight-loss medicine from Novo Nordisk.
In the coming years, household consumption is expected to be strengthened by rising real wages and a resilient labour market. Increased defence investment and construction activity are also expected to contribute to growth.
HICP inflation is expected to come in at 1.7 percent this year, before rising to 2.7 percent in 2027 and 2.5 percent in 2028. The temporary reduction in the electricity tax is helping to keep inflation down this year, while the reinstatement of the tax in 2028 is expected to push up prices.
Unemployment is expected to remain relatively stable at 7.0 percent both this year and next year, before rising marginally to 7.1 percent in 2028.
Denmark’s public finances are expected to continue to show a surplus, but this is set to shrink as a result of increased spending on, among other things, defence and support for Ukraine. The budget surplus is expected to amount to 1.1 percent of GDP this year, 0.5 percent in 2027 and 0.3 percent in 2028.
At the same time, public debt is expected to decrease from 26.2 percent of GDP this year to 25.2 percent in 2028.